Table 1
Summarised data of four quadrant repeated corneal transplanted patients treated and untreated with systemic cyclosporin A
| Parameter | Regrafts treated with cyclosporin A | Regrafts untreated with cyclosporin A |
|---|---|---|
| LP = light perception, NLP = no light perception. | ||
| Number of regrafts | 28 | 12 |
| Follow up (months) | ||
| Average | 26 | 20 |
| Range | 6–106 | 2–65 |
| Cyclosporin A treatment (months) | ||
| Average | 12 | |
| Range | 1–41 | |
| Regraft survival (months) | ||
| Average | 16.1 | 10.9 |
| Range | 1–40 | 1–36 |
| Survival of regrafts complicated by immune rejection (months) | ||
| Average | 16.5 | 18.8 |
| Range | 10–40 | 3–36 |
| Survival of regrafts with other complications (months) | ||
| Average | 17.6 | 5.2 |
| Range | 1–39 | 1–11 |
| Number of failed regrafts | 19 (68%) | 11 (92%) |
| Number of failed regrafts due to immune rejection | 9 (32%) | 5 (42%) |
| Visual acuity at presentation | LP–20/100 | LP–20/100 |
| Final visual acuity | NLP–20/30 | LP–20/200 |
